중환자실에서 전기 임피던스 단층 촬영을 통한 폐 기능 모니터링

Executive Industry Relevance

Electrical Impedance Tomography (EIT) enables continuous, non-invasive, and radiation-free monitoring of lung ventilation and perfusion in critical care settings. Its real-time, regional imaging capabilities address a key gap in respiratory monitoring, supporting rapid, data-driven decisions for patient management. EIT's quantitative outputs and dynamic visualization are highly relevant for translational research and early-stage respiratory device development.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Supports mechanistic de-risking by quantifying regional lung function in heterogeneous disease models.
• Enables functional validation of respiratory targets through real-time assessment of ventilation and perfusion changes.
• Facilitates hypothesis testing on the impact of interventions or patient positioning on lung mechanics.

Screening & Assay Development

• Provides standardized, reproducible imaging outputs for evaluating respiratory interventions in preclinical or translational models.
• Delivers quantitative, spatially resolved data suitable for assay development and screening of ventilatory support strategies.
• Enables rapid assessment of device or compound effects on lung function, supporting scalable evaluation workflows.

Translational & Preclinical Research

• Aligns with disease-relevant endpoints by mapping ventilation/perfusion mismatch and regional lung responses.
• Supports continuity from discovery through preclinical validation by enabling bedside-to-bench translation of respiratory metrics.
• Reduces biological risk in advancing respiratory therapies by providing predictive, real-time functional readouts.

Pipeline & Workflow Integration

EIT integrates into the respiratory discovery continuum from early mechanistic studies to preclinical validation, enabling iterative optimization of interventions and device settings.

• Discovery Biology: Quantifies regional lung function to clarify mechanisms and validate respiratory targets.
• Screening: Offers reproducible, quantitative imaging outputs for evaluating intervention efficacy.
• Analytics: Provides real-time, spatially resolved data for statistical comparison of ventilation and perfusion patterns.
• Translational Research: Bridges clinical and preclinical workflows by enabling bedside-relevant functional assessments.
• Enterprise Reuse: Establishes a reusable platform for respiratory monitoring across diverse models and studies.

Operational & Enterprise Impact

• Scientific Value: Enhances predictive confidence and target validation by reducing ambiguity in lung function assessment.
• Operational Value: Standardizes respiratory monitoring with scalable, reproducible, and non-invasive imaging.
• Strategic Value: Informs go/no-go decisions and optimizes resource allocation by providing actionable, real-time data.
• Portfolio Impact: Supports risk-adjusted prioritization of respiratory assets and interventions.

Implementation Considerations

• Requires expertise in electrode placement and interpretation of impedance-based imaging.
• Needs access to EIT instrumentation and compatible analytical software.
• Demands cross-team standardization for data acquisition and analysis protocols.
• Adaptable across adult and pediatric models with appropriate belt sizing and positioning.
• Signal quality and interpretation may be affected by patient movement or improper setup.

Biopharma FAQs